HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) All Versions of this Article: db07-1104v1 db07-1104v2 57/4/967    most recent Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Granata, R. Articles by Ghigo, E. PubMed PubMed Citation Articles by Granata, R. Articles by Ghigo, E. Social Bookmarking                What's this?

OBESTATIN PROMOTES SURVIVAL OF PANCREATIC β-CELLS AND HUMAN ISLETS AND INDUCES EXPRESSION OF GENES INVOLVED IN THE REGULATION OF β-CELL MASS AND FUNCTION

¹Laboratory of Molecular and Cellular Endocrinology
²Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Turin, Turin, Italy
³Department of Medicine, Transplant Unit, Scientific Institute San Raffaele, Vita-Salute University, Milan, Italy
⁴Department of Pharmaceutical Sciences, University of Salerno, Fisciano (Salerno), Italy
⁵Department of Anatomy, Pharmacology and Forensic Medicine and
⁶Department of Clinical and Biological Sciences and San Luigi Hospital, University of Turin, Turin, Italy

Objective: Obestatin is a newly discovered peptide encoded by the ghrelin gene whose biological functions are poorly understood. We investigated obestatin effect on survival of β-cells and human pancreatic islets and the underlying signaling pathways.

Research Design and Methods: β-cells and human islets were used to assess obestatin effect on cell proliferation, survival, apoptosis, intracellular signaling and gene expression.

Results: Obestatin showed specific binding on HIT-T15 and INS-1E β-cells, bound to GLP-1R and recognized ghrelin binding sites. Obestatin, exerted proliferative, survival and antiapoptotic effects, under serum deprived conditions and IFN-/TNF-/IL-1β treatment, particularly at pharmacological concentrations. Ghrelin receptor antagonist [D-Lys³]-GHRP-6 and anti-ghrelin antibody prevented obestatin-induced survival in β-cells and human islets. β-cells and islet cells released obestatin and addition of anti-obestatin antibody reduced their viability. Obestatin increased β-cell cAMP and activated ERK1/2 and PI3K/Akt; its antiapoptotic effect was blocked by inhibition of AC/cAMP/PKA, PI3K/Akt and ERK1/2 signaling. Moreover, obestatin up-regulated GLP-1R mRNA and IRS-2 expression and phosphorylation. The GLP-1R antagonist exendin-(9-39) reduced obestatin effect on β-cell survival. In human islets, obestatin, whose immunoreactivity co-localized with that of ghrelin, promoted cell survival and blocked cytokine-induced apoptosis through cAMP increase and involvement of AC/cAMP/PKA signaling. Moreover, obestatin: i) induced PI3K/Akt, ERK1/2 and also CREB phosphorylation; ii) stimulated insulin secretion and gene expression; iii) up-regulated GLP-1R, IRS-2, PDX-1 and glucokinase mRNA.

Conclusions: These results indicate that obestatin promotes β-cell and human islet cell survival and stimulates the expression of main regulatory β-cell genes, identifying a new role for this peptide within the endocrine pancreas.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?